Share  Print  [-] [+]

OrbusNeich Medical Group Limited Raises Over US$200 million in Recent Rounds of Fundraising

Monday, August 30, 2021

(Press Release) - OrbusNeich Medical Group Limited (“OrbusNeich”), a leading medical device manufacturer headquartered in Hong Kong and specialising in the design, production and sales of innovative products for vascular intervention, has raised over US$200 million in two recently concluded fundraising rounds. The participating investors include Shenzhen Capital Group (together with its healthcare investment fund, Red Earth Healthcare Investment Fund), CCB International, CICC Biomedical Fund L.P. of CICC Capital, China Merchants Securities Investment, Shenzhen Share Capital Healthcare Fund and other well-known family offices. The proceeds raised will enable OrbusNeich to further invest in research and development activities and accelerate its growth in new and existing product areas, both in Greater China and overseas.


View full announcment here